FDA Warns Abbott Coronavirus Tests Could Be Inaccurate

The alert comes after an NYU study showed the company’s tests missed diagnosing up to half of known positive cases.

Read the full post on Forbes - Healthcare

Rachel Sandler, Forbes Staff